A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
Clinical trial NCT04623021 · COMPLETED
Trial details
- NCT number
- NCT04623021
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2020-12-12
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.